October 28, 2025

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring Solid Revenue Growth and Analyst Enthusiasm

GeneDx Holdings Corp. (WGS), a key player in the genomics sector, has been capturing the attention of investors with its remarkable 45.60% revenue growth. This impressive figure, combined with robust..

Merus N.V. (MRUS) Stock Analysis: Evaluating the 2.54% Upside Potential in Biotechnology’s Dynamic Landscape

Merus N.V. (MRUS), a Netherlands-based biotechnology company, stands out in the healthcare sector with a market capitalization of $7.17 billion. Specializing in the development of innovative antibody therapeutics, Merus is..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Complex Landscape with a 2.99% Dividend Yield

Premier, Inc. (NASDAQ: PINC) is a prominent player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $2.32 billion, Premier is headquartered in..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Unpacking a Potential 227% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a dynamic player in the biotechnology sector, is currently making waves in the investment community with a potential upside of 227.75%. The company, headquartered in..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with a 95% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its considerable potential in the biotechnology sector, evidenced by a striking 95.21% upside potential based on analyst price..

Indivior PLC (INDV) Stock Analysis: Promising 17.7% Upside Potential Amidst Rising Demand for Opioid Treatment Solutions

Indivior PLC (INDV), a major player in the healthcare sector, focuses on developing prescription medications for opioid dependence and related disorders. With a market capitalization of $3.09 billion, the company..

Belite Bio, Inc (BLTE) Stock Analysis: Navigating the Biotech Frontier with Promising Clinical Trials

Belite Bio, Inc (BLTE), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector. With a current market capitalization of $3.27 billion, this San Diego-based company focuses on..

Immunocore Holdings plc (IMCR) Investor Outlook: Exploring an 85.88% Potential Upside in Biotech

Immunocore Holdings plc (IMCR) stands out in the biotechnology sector, promising significant growth opportunities for investors with its impressive pipeline of immunotherapies. With a current market capitalization of $1.69 billion,..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 16% Upside Potential and Robust Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors focused on the healthcare sector, particularly within the niche of medical instruments and supplies. With a market capitalization of..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges Amidst a Transformative Healthcare Landscape

In the complex and rapidly evolving landscape of healthcare, BGM Group Ltd. (BGM), a China-based company, stands as a noteworthy player in the specialty and generic drug manufacturing industry. Despite..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 16.72% Potential Upside with Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (MIRM) is making waves in the biotech sector, attracting investors with its innovative approach to tackling rare and orphan diseases. With a market capitalization of $3.6 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Innovator with a Staggering 187% Potential Upside

Janux Therapeutics, Inc. (JANX) is capturing the spotlight within the biotechnology sector, not only for its innovative approach to cancer treatment but also for its remarkable potential upside of 187.34%,..

Organon & Co. (OGN) Stock Analysis: Examining the 53% Potential Upside Amidst Healthcare Headwinds

Organon & Co. (NYSE: OGN) is a prominent player in the healthcare sector, specifically within the drug manufacturers industry. With a market capitalization of $1.84 billion, the company is a..

Select Medical Holdings Corp (SEM) Stock Analysis: Uncovering a 26.67% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) is making waves in the healthcare sector with its diverse portfolio of medical care facilities. With a market capitalization of $1.76 billion, Select Medical..

Surgery Partners, Inc. (SGRY) Investor Outlook: Unpacking a 34.58% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY), a significant player in the medical care facilities industry, stands as a compelling opportunity for investors eyeing the healthcare sector. With a market capitalization of..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling a 12% Potential Upside for Biotech Enthusiasts

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector with its innovative approach to drug development, focusing on small molecule therapeutics that leverage the body’s natural protein..

Phreesia, Inc. (PHR) Stock Analysis: Healthcare SaaS Leader with 44% Upside Potential

Phreesia, Inc. (NYSE: PHR), a key player in the healthcare sector, offers a compelling investment narrative for investors seeking exposure to the rapidly evolving Health Information Services industry. With its..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Evaluating a 29.86% Potential Upside in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Swiss-based clinical-stage biotechnology company, is capturing the attention of investors with its promising research in inflammatory skin and joint diseases. Despite the challenges inherent in..

PACS Group, Inc. (PACS) Stock Analysis: Unpacking a 175% Potential Upside

PACS Group, Inc. (PACS), a prominent player in the healthcare sector, is capturing investor attention with its considerable potential upside of 175.13%. As a company specializing in skilled nursing and..

Enovis Corporation (ENOV) Stock Analysis: A Robust 51.15% Potential Upside Captures Investor Attention

Enovis Corporation (ENOV), a key player in the healthcare sector’s medical device industry, presents a compelling case for investors seeking growth opportunities within this dynamic field. With a market capitalization..

Search

Funds

October 28, 2025

Search

Funds

October 28, 2025

FTSE 100

Funds